MAP2K7 and Alzheimer disease: We explored whether DHCR24 downregulation affects tau hyperphosphorylation in astrocytic tauopathy through the activation of lipid rafts/caveolae-dependent RAS/MEK/ERK signaling, which could contribute to the tauopathy in AD and other neurodegenerative diseases.